Search

Presidential Speakers

Promising crucial developments in the field of hematology, the speakers and presentation topics of the EHA2025 Presidential Session speakers are now available. Friday, June 13, 2025 - Presidential Session I

Immunotherapy (TCR related)

Prof.

Read more

EHA Education & Mentoring Award

“Educating and mentoring are a brain to pick, an ear to listen, and a push in the right direction. ”

Through this award, EHA recognized excellent teachers and mentors at any stage of their career.

Read more

Spotlight on...

We talk to leaders, thinkers and influencers to hear their thoughts on #changeOfMindset #HotInHematology to provide a #VisionOfYourFuture.

Read more

Addition of obinutuzumab (GA101) or rituximab to chlorambucil improves outcomes for elderly patients with chronic lymphocytic leukemia (CLL) and co-existing medical conditions (comorbidities)

CLL is the most common leukemia in the western world. Many CLL patients are elderly and have comorbidities rendering them ineligible for aggressive standard treatments.

Read more

EHA donates €250,000 to Médecins Sans Frontières

The EHA Board is actively implementing support actions to hematologists and hematology patients in Ukraine and to those who are forced to leave the country.

Read more

EHA and Polish Society’s third tutorial together focused on myeloid and lymphoid leukemias

Seventy-five participants from Europe and the Middle East learned about the advances in biology, genetic characteristics, diagnostic approaches and therapy of leukemias during the EHA-PTHiT Hematology Tutorial on Myeloid and Lymphoid Leukemias in Warsaw, Poland.

Read more